Tikaros

Developer of immunotherapies for the treatment of cancer

placeSeoul, Seoul, South Korea calendar_todayFounded 2018 language ticaros.com

Registered entities

Investor mix

6 investors on record; lead investors include Shinhan Venture Investment, UTC Investment, Woori Investment Bank, KOSME.

Investor typeCountShare
Venture capital350%
Private equity117%
Bank & private debt117%
Other / undisclosed117%
Coming soon